As of January 22, 2025, Werewolf Therapeutics (HOWL) has a market cap of $60.606 million USD. According to our data, Werewolf Therapeutics is ranked No.8041 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $60.61 M |
-8.11%
|
Dec 31, 2024 | $65.95 M |
-61.66%
|
Dec 29, 2023 | $0.17 B |
88.29%
|
Dec 30, 2022 | $91.35 M |
-82.79%
|
Dec 31, 2021 | $0.53 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.15 B |
0.000 M
|
UK
|
Atara Biotherapeutics
ATRA
|
$39.68 M |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Market Cap | = | HOWL Stock Price | * | HOWL Shares Outstanding |
= | $1.36 | * | 44.56 M | |
= | $60.61 M |